Application of co-culture technology of epithelial type cells and mesenchymal type cells using nanopatterned structures.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2020
Historique:
received: 30 12 2019
accepted: 23 04 2020
entrez: 12 5 2020
pubmed: 12 5 2020
medline: 6 8 2020
Statut: epublish

Résumé

Various nanopatterning techniques have been developed to improve cell proliferation and differentiation efficiency. As we previously reported, nanopillars and pores are able to sustain human pluripotent stem cells and differentiate pancreatic cells. From this, the nanoscale patterns would be effective environment for the co-culturing of epithelial and mesenchymal cell types. Interestingly, the nanopatterning selectively reduced the proliferative rate of mesenchymal cells while increasing the expression of adhesion protein in epithelial type cells. Additionally, co-cultured cells on the nanopatterning were not negatively affected in terms of cell function metabolic ability or cell survival. This is in contrast to conventional co-culturing methods such as ultraviolet or chemical treatments. The nanopatterning appears to be an effective environment for mesenchymal co-cultures with typically low proliferative rates cells such as astrocytes, neurons, melanocytes, and fibroblasts without using potentially damaging treatments.

Identifiants

pubmed: 32392240
doi: 10.1371/journal.pone.0232899
pii: PONE-D-19-35930
pmc: PMC7213697
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0232899

Commentaires et corrections

Type : ErratumIn

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist. T&R Biofab Co. Ltd and Amorepacific Corporation do not alter our adherence to PLOS ONE policies on sharing data and materials.

Références

Br J Dermatol. 1994 Dec;131(6):836-42
pubmed: 7857836
Biochem Biophys Res Commun. 2014 Jan 24;443(4):1176-81
pubmed: 24406164
Trends Mol Med. 2006 Sep;12(9):440-50
pubmed: 16899408
Exp Cell Res. 2007 May 15;313(9):1820-9
pubmed: 17428465
Cell Stem Cell. 2009 Jul 2;5(1):17-26
pubmed: 19570510
Acta Biomater. 2009 Jun;5(5):1433-41
pubmed: 19208503
Leuk Lymphoma. 2000 Sep;39(1-2):19-27
pubmed: 10975380
Curr Eye Res. 2001 Mar;22(3):174-81
pubmed: 11462153
Science. 2009 Jun 26;324(5935):1673-7
pubmed: 19556500
Nat Mater. 2007 Dec;6(12):997-1003
pubmed: 17891143
Macromol Biosci. 2012 Nov;12(11):1480-9
pubmed: 23042782
ACS Nano. 2016 Mar 22;10(3):3342-55
pubmed: 26900863
Science. 2006 Mar 31;311(5769):1880-5
pubmed: 16574858
FASEB J. 2004 Nov;18(14):1716-8
pubmed: 15345697
Annu Rev Cell Dev Biol. 2010;26:533-56
pubmed: 20590452
Mater Sci Eng C Mater Biol Appl. 2019 Oct;103:109729
pubmed: 31349510
Angew Chem Int Ed Engl. 2011 Jan 3;50(1):200-42
pubmed: 21184400
Acta Biomater. 2009 Sep;5(7):2451-9
pubmed: 19394284
Nat Commun. 2019 Jul 16;10(1):3123
pubmed: 31311935
Philos Trans R Soc Lond B Biol Sci. 1999 Sep 29;354(1389):1571-5; discussion 1575-6
pubmed: 10582242
Science. 1998 Nov 6;282(5391):1145-7
pubmed: 9804556
Stem Cells Int. 2017;2017:7859184
pubmed: 28197209
Nature. 2009 Nov 26;462(7272):433-41
pubmed: 19940913
Wound Repair Regen. 2010 Jan-Feb;18(1):114-22
pubmed: 20082684
Biomaterials. 2013 May;34(16):4013-4026
pubmed: 23465823
Biochem Biophys Res Commun. 2007 Jan 19;352(3):675-80
pubmed: 17141200
J Biomol Screen. 2015 Mar;20(3):422-9
pubmed: 25381255
Exp Cell Res. 1999 Feb 1;246(2):384-94
pubmed: 9925754
J R Soc Interface. 2014 Jul 6;11(96):
pubmed: 24829281
Biomaterials. 2010 Feb;31(6):1299-306
pubmed: 19879643
Stem Cell Rev Rep. 2010 Mar;6(1):96-107
pubmed: 20012714
Curr Opin Cell Biol. 1996 Oct;8(5):618-24
pubmed: 8939648
Proc Natl Acad Sci U S A. 1997 Feb 4;94(3):855-60
pubmed: 9023346
Cornea. 2000 Jan;19(1):57-64
pubmed: 10632010
Annu Rev Biophys. 2012;41:519-42
pubmed: 22404680
Biomaterials. 2014 Jan;35(3):916-28
pubmed: 24183167
Crit Rev Biomed Eng. 2010;38(5):393-433
pubmed: 21175407

Auteurs

Taek-Hee Jung (TH)

Research Institute, T&R Biofab Co. Ltd, Siheung, Republic of Korea.

Eun-Bin Chung (EB)

Department of Stem Cell Biology, School of Medicine, Konkuk University, Seoul, Republic of Korea.

Hyung Woo Kim (HW)

Department of Mechanical Engineering, Pohang University of Science and Technology, (POSTECH) Pohang, Pohang, Republic of Korea.

Seong Woo Choi (SW)

Ischemic/Hypoxic Disease Institute, Seoul National University College of Medicine, Seoul, Republic of Korea.

Soon-Jung Park (SJ)

Research Institute, T&R Biofab Co. Ltd, Siheung, Republic of Korea.

Anthony Safaa Mukhtar (AS)

Research Institute, T&R Biofab Co. Ltd, Siheung, Republic of Korea.

Hyung-Min Chung (HM)

Department of Stem Cell Biology, School of Medicine, Konkuk University, Seoul, Republic of Korea.

Eunmi Kim (E)

R&D Unit, Amorepacific Corporation, Yongin-si, Gyeonggi-do, Republic of Korea.

Kang Moo Huh (KM)

Department of Polymer Science and Engineering Chungnam National University, Daejeon, Republic of Korea.

Dong Sung Kim (DS)

Department of Mechanical Engineering, Pohang University of Science and Technology, (POSTECH) Pohang, Pohang, Republic of Korea.

Sun-Woong Kang (SW)

Research Group for Biomimetic Advanced Technology, Korea Institute of Toxicology, Daejeon, Republic of Korea.
Department of Human and Environmental Toxicology, University of Science and Technology, Daejeon, Republic of Korea.

Sung-Hwan Moon (SH)

Research Institute, T&R Biofab Co. Ltd, Siheung, Republic of Korea.
Department of Medical Science, School of Medicine, Konkuk University, Seoul, Republic of Korea.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH